Collaborative research conducted at McMaster University, Syracuse University and Molecular Insight Pharmaceuticals, Inc. demonstrates the expansion of the company’s Single Amino Acid Chelate (SAAC(TM)) technology for use with fluorescent microscopy. The new fluorescence-based technology called SAACQ(TM) enables the visualization of radiopharmaceuticals interacting with cellular structures. This advance promises to accelerate the development of molecular imaging pharmaceuticals and targeted radiotherapeutics. The results were published in today’s Journal of the American Chemical Society (JACS).
